Table 1. The relationship between LDLRAD2 expression and clinicopathological features of patients with gastric cancer.

	LDLRAD2 expression
Clinicopathological features	Low	High	P value (χ2 test)
Age (y)			0.520
≤50	30	26
>50	60	64
Gender			0.739
Male	64	66
Female	26	24
Lauren			0.230
Intestinal	12	18
Diffuse	78	72
Clinical stage			0.013
I	8	2
II	27	16
III	36	38
IV	19	34
T classification			0.151
T1+T2+T3	24	16
T4	66	74
N classification			<0.001
N0	33	13
N1-N3	57	77
Distant metastasis			0.023
M0	84	74
M1	6	16